Xiangxue Pharmaceutical Co (SZSE:300147) Total Liabilities : ¥6,085 Mil (As of Mar. 2025)

View and export this data going back to 2010. Start your Free Trial

What is Xiangxue Pharmaceutical Co Total Liabilities?

Xiangxue Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 was ¥6,085 Mil.

Xiangxue Pharmaceutical Co's quarterly Total Liabilities increased from Sep. 2024 (¥5,937.42 Mil) to Dec. 2024 (¥6,059.57 Mil) and increased from Dec. 2024 (¥6,059.57 Mil) to Mar. 2025 (¥6,084.94 Mil).

Xiangxue Pharmaceutical Co's annual Total Liabilities increased from Dec. 2022 (¥5,922.02 Mil) to Dec. 2023 (¥5,967.41 Mil) and increased from Dec. 2023 (¥5,967.41 Mil) to Dec. 2024 (¥6,059.57 Mil).

Xiangxue Pharmaceutical Co Total Liabilities Historical Data

The historical data trend for Xiangxue Pharmaceutical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Xiangxue Pharmaceutical Co Total Liabilities Chart

Xiangxue Pharmaceutical Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Total Liabilities

Get a 7-Day Free Trial

7,951.05

7,032.83

5,922.02

5,967.41

6,059.57

Xiangxue Pharmaceutical Co Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Total Liabilities	Get a 7-Day Free Trial															5,955.21	5,923.41	5,937.42	6,059.57	6,084.94

Xiangxue Pharmaceutical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Xiangxue Pharmaceutical Co's Total Liabilities for the fiscal year that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5382.017	+	(601.515	+	65.618
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	10.416)
	=	6,060

Total Liabilities	=	Total Assets (A: Dec. 2024 )	-	Total Equity (A: Dec. 2024 )
	=	7498.399	-	1438.833
	=	6,060

Xiangxue Pharmaceutical Co's Total Liabilities for the quarter that ended in Mar. 2025 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	5777.245	+	(231.828	+	65.453
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0	+	0	+	10.416)
	=	6,085

Total Liabilities	=	Total Assets (Q: Mar. 2025 )	-	Total Equity (Q: Mar. 2025 )
	=	7443.66	-	1358.718
	=	6,085

Xiangxue Pharmaceutical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Xiangxue Pharmaceutical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Xiangxue Pharmaceutical Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Xiangxue Pharmaceutical Co Ltd (SZSE:300147) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

No 2 Jinfeng Road , Science City, Guangzhou Economic and Technological Development Z, Guangzhou, CHN, 510663

Website

http://www.xphcn.com

Xiangxue Pharmaceutical Co Ltd is a China-based company engages in the manufacture and distribution of pharmaceutical products. Its diversified healthcare portfolio includes Chinese Herbal Slices, TCM, Life Science, Biomedical Engineering health solutions (food and beverage), healthcare supplements and so on.

Executives

Huang Wei Hua	Supervisors
Tan Wen Hui	Director
Kang Zhi Ying	Executives
Ceng Lun	Executives
Liu Yan	Executives
Lu Feng	Executives
Xu Li	Secretary, Director
Mo Zi Yu	Supervisors
Mai Zhen Jiang	Supervisors
Wang Yong Hui	Directors, executives
He Tao	Executives
Fang Wei Min	Supervisors
Huang Bin	Directors, Directors, and Executives
Wu Jun	Executives
Chen Wen Jin	Executives

Xiangxue Pharmaceutical Co Headlines

No Headlines